Skip to content

Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain

Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06377969
Enrollment
10
Registered
2024-04-22
Start date
2025-06-01
Completion date
2028-05-31
Last updated
2026-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pelvic Pain Syndrome

Brief summary

Spinal cord stimulation (SCS) is an effective treatment for patients with chronic pelvic pain. The investigators will evaluate how safe and effective closed-loop spinal cord stimulation is in treating these patients; closed-loop spinal cord stimulation is a more novel method in delivering spinal cord stimulation that controls energy output of the device based on real-time feedback on how the device is stimulating the spinal cord.

Interventions

DEVICEECAP (Evoked Compound Action Potential)-controlled Closed-Loop Spinal Cord Stimulation

The patients will receive externalized epidural leads connected to external pulse generator for 5-14 days during trial phase. If the trial results in \>50% reduction in pain, they will undergo a minor surgery to receive implantable spinal cord stimulator

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Pilot prospective single arm interventional study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The investigators will include all adult patients (18 or older) with pelvic pain more than 6 months that has not responded to conservative medical management

Exclusion criteria

* Major untreated medical comorbidities (uncontrolled diabetes mellitus, severe obesity, uncontrolled cardiopulmonary disease, etc.) * Secondary causes of pelvic pain that can be treated with appropriate medical or surgical interventions * Major untreated psychological comorbidities * Anatomical challeneges to place spinal cord stimulator * Ongoing legal or disability claims

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain IntensityBaseline, 3-month, 6-month and 12-monthNumerical Rating Scale (0-10; higher score is worse)

Secondary

MeasureTime frameDescription
Change in DisabilityBaseline, 3-month, 6-month and 12-monthPain Disability Index
Patient Global Impression ChangeBaseline, 3-month, 6-month and 12-month7-point Likert Scale
Change in Quality of LifeBaseline, 3-month, 6-month and 12-monthShort Form McGill Pain Questionnaire
Change in Pain Catastrophizing ScaleBaseline, 3-month, 6-month and 12-month14-item questionnaire scoring 0-52 (higher score worse)
Change in sleep qualityBaseline, 3-month, 6-month and 12-monthPROMIS (Patient Reported Outcomes Measure Information System) Sleep Disturbance (t-score and percentile)
Change in Social FunctioningBaseline, 3-month, 6-month and 12-monthPROMIS Satisfaction with social roles and activities (t-score and percentile)

Countries

United States

Contacts

CONTACTVafi Salmasi, MD
vsalmasi@stanford.edu6507250246

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026